Accelerating the path to a non-opioid future.

Committed to finding new, safe ways to alleviate human suffering responsibly.

Learn More

For too long, the options for those in chronic and acute pain have been too limited.

Today, CerSci is poised to deliver a new generation of non-opioid medicines to treat acute post-operative and chronic neuropathic pain.

A new approach to developing novel pain therapeutics.

Rather than concentrating on ion channel and GPCR targets, CerSci's science is focused on interrupting pathways that cause pain. This mandate sets CerSci apart from other more common approaches to treating pain.

See the Research

Prevention / Alleviation

of tractile allodynia, thermal hyperalgesia, and mechanical hypersensitivity

Sustained relief

Single dose can last for days

Lack of tolerance

Across all species so far

No GI ulceration

or genotoxicity signals

No sedation

or motor impairment side effects

No tolerance

No effects on core body temperature

CT-044, a powerful reactive species decomposition accelerant.

Learn more about the science behind Cersci’s lead molecular asset here.

Learn More

A mission equal parts scientific and humanitarian.

Cersci was founded to deliver much needed new medicines through understanding the underlying mechanisms behind pain, and conquering the core problem of neuronal sensitization.